Neuroendocrine tumours: open trials in Denmark

• NCT04924075

  Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

  Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC

  Rigshospitalet (Site 0304), Copenhagen · Rigshospitalet-Department of Endocrinology (Site 0303), Copenhagen · Odense Universitetshospital (Site 0302), Odense C

  Registry updated 2026-11-03

• NCT07544654

  DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

  Trial Treatment · Phase 3 · Boehringer Ingelheim

  Region Midtjylland, Aarhus N · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C

  Registry updated 2026-10-28

• 2025-524160-38-00

  A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Region Hovedstaden, Herlev

  Registry updated 2026-10-01

• 2024-520050-38-00

  Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide versus Durvalumab, Carboplatin, and Etoposide in First-Line ES-SCLC (DeLLphi-312)

  Trial Treatment · Phase 3 · Amgen Inc.

  Rigshospitalet, Copenhagen Oe · Region Midtjylland, Herning

  Registry updated 2026-08-12

• NCT04917484

  Dosimetry Based PRRT Versus Standard Dose PRRT With Lu-177-DOTATOC in NEN Patients

  Trial Treatment · Phase 2 · Tine Gregersen, MD

  Aarhus University Hospital, department of Nuclear medicine and PET centre, Aarhus

  Registry updated 2024-12-09

• 2024-517240-62-00

  Dosimetry based PRRT versus standard dose PRRT with Lu-177-DOTATOC in NEN patients- a randomized study; a step towards tailored PRRT.

  Trial Treatment · Phase 2 · Region Midtjylland

  Region Midtjylland, Aarhus N

  Registry updated 2024-11-04

• NCT04788927

  Development of a Predictive Model for the Risk of Metastatic Disease in PPGLs, a Retrospective Cohort Study

  Research · Copenhagen University Hospital, Rigshospitalet

  Rigshospitalet, Copenhagen · National University Hospital, Department of Medical Endocrinology, Copenhagen

  Registry updated 2023-04-07

All Neuroendocrine tumours trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error